Literature DB >> 35557580

Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance.

Shen Wang1, Jien Guo1, Zhenzhou Mo1, Xiangcheng Shi2, Chongxiao Qu2.   

Abstract

Background: Poor prognosis is common in gastric cancer patients due to multidrug resistance (MDR)-induced recurrence and metastasis. In the present study, we investigated the expression of microRNA (miR)-200c in gastric cancer tissues and cell lines and its relationship with the expression of the drug resistant gene ABCB1, which encodes P-glycoprotein (P-gp).
Methods: The basic characteristics of 102 patients with gastric cancer were reviewed. Real time-polymerase chain reaction (PCR), immunohistochemistry, and Western blot were employed to detect the expression levels of miR-200c and P-gp in gastric carcinoma tissues and cell lines. The correlation of miR-200c messenger RNA (mRNA) level with clinicopathological characteristics and P-gp protein expression were analyzed. SGC7901/vincristine (VCR) cells were transfected with miR-200c mimics or a specific small interfering RNA (siRNA) targeting the ABCB1 gene. The methyl thiazolyl tetrazolium (MTT) assay and flow cytometry were used to determine the role of miR-200c and ABCB1 on the viability and apoptosis of gastric carcinoma cell lines.
Results: The level of miR-200c in carcinoma tissues was significantly lower than that in adjacent tissues, and the expression level of P-gp in carcinoma tissues was obviously higher than that in adjacent tissues (P<0.01, P=0.029). The expression levels of miR-200c and P-gp were associated with the malignant characteristics of gastric cancer, and patients with high expression of miR-200c or negative expression of P-gp had a better prognosis (P=0.006, P=0.022). MiR-200c negatively regulated the ABCB1 gene in gastric cancer cell lines. MiR-200c overexpression and ABCB1 down-regulation increased the sensitivity of SGC7901/VCR cells to VCR and reversed MDR by promoting cell apoptosis. Conclusions: The expression level of miR-200c decreases in gastric carcinoma tissues and drug-resistant gastric cancer SGC7901/VCR cells. Overexpression of miR-200c may enhance the sensitivity of SGC7901/VCR cells to VCR by regulating the expression of P-gp. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Gastric carcinoma; P-glycoprotein (P-gp); SGC-7901; microRNA (miR)-200c; multidrug resistance (MDR)

Year:  2022        PMID: 35557580      PMCID: PMC9086044          DOI: 10.21037/jgo-22-167

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  30 in total

1.  Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

Authors:  Sergio Marchini; Duccio Cavalieri; Robert Fruscio; Enrica Calura; Daniela Garavaglia; Ilaria Fuso Nerini; Costantino Mangioni; Giorgio Cattoretti; Luca Clivio; Luca Beltrame; Dionyssios Katsaros; Luca Scarampi; Guido Menato; Patrizia Perego; Giovanna Chiorino; Alessandro Buda; Chiara Romualdi; Maurizio D'Incalci
Journal:  Lancet Oncol       Date:  2011-02-21       Impact factor: 41.316

Review 2.  ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.

Authors:  Louise Hill; Gareth Browne; Eugene Tulchinsky
Journal:  Int J Cancer       Date:  2012-07-21       Impact factor: 7.396

3.  Downregulation of miR‑200c‑3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2.

Authors:  Junqing Chen; Wei Tian; Haifei He; Feng Chen; Jian Huang; Xiaojia Wang; Zhanhong Chen
Journal:  Oncol Rep       Date:  2018-09-26       Impact factor: 3.906

4.  Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.

Authors:  Diana M Cittelly; Irina Dimitrova; Erin N Howe; Dawn R Cochrane; Annie Jean; Nicole S Spoelstra; Miriam D Post; Xian Lu; Russell R Broaddus; Monique A Spillman; Jennifer K Richer
Journal:  Mol Cancer Ther       Date:  2012-10-16       Impact factor: 6.261

5.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

Authors:  Shujing Liu; Michael T Tetzlaff; Rutao Cui; Xiaowei Xu
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

6.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Authors:  Hua Yang; William Kong; Lili He; Jian-Jun Zhao; Joshua D O'Donnell; Jiawang Wang; Robert M Wenham; Domenico Coppola; Patricia A Kruk; Santo V Nicosia; Jin Q Cheng
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

7.  Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients.

Authors:  Jie Sun; Jingjing Zhao; Zhenkun Yang; Zhiyi Zhou; Peihua Lu
Journal:  J Gastrointest Oncol       Date:  2021-04

8.  miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.

Authors:  Jing Li; Qiang Tan; Mingxia Yan; Lei Liu; Hechun Lin; Fangyu Zhao; Guoliang Bao; Hanwei Kong; Chao Ge; Fanglin Zhang; Tao Yu; Jinjun Li; Xianghuo He; Ming Yao
Journal:  Mol Cancer       Date:  2014-07-06       Impact factor: 27.401

9.  MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.

Authors:  Po-Len Liu; Wei-Lun Liu; Jia-Ming Chang; Yung-Hsiang Chen; Yu-Peng Liu; Hsuan-Fu Kuo; Chong-Chao Hsieh; Yu-Sian Ding; Wei-Wei Chen; Inn-Wen Chong
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.